6K Appoints Former Allstate CEO and Chairman Edward Liddy to its Board of Directors
This appointment brings peerless experience as a previous board member of Boeing, 3M, Abbott and Goldman Sachs to support 6K’s accelerated growth
Battery Leaders Voltaiq, Batemo and Energy Assurance Release First Independent Battery Index
First independent Battery Index provides the ‘missing link’ for manufacturers of battery-powered products from consumer electronics to EVs
Battery Analytics Leader Voltaiq Names Tech Executive Martin Thall President and COO
Thall brings 30+ years of computer technology experience with Microsoft, Verizon and Visteon
InterVenn Biosciences Names Brian Hogan as Chief Financial Officer
Life sciences industry veteran brings decades of experience in public and private companies to scale the company’s capabilities and operations for accelerated growth
InterVenn Biosciences to Present at the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022
InterVenn Biosciences is scheduled to present at the J.P. Morgan 40th Annual Healthcare Conference on January 12, 2022.
GelSight Blazes Forward with Several Award Wins Recognizing its Innovations in Tactile Intelligence
Share on twitter Share on linkedin WALTHAM, Mass.–(BUSINESS WIRE)–GelSight, a pioneer in tactile intelligence technology, announced today that it has been selected as a winner in Fast Company’s Next Big Things in Tech 2021 in the Smart Machines category, a 2021 BostInno on Firehonoree in the Robotics category, and the winner of the 2021 Eddie […]
InterVenn Presents Results Detailing Glycoproteomic Signature Predictive of Response to Immune Checkpoint Inhibitor Treatment in Advanced Non-Small Cell Lung Cancer at American Society for Immunotherapy of Cancer
Results presented on a predictive signature capable of identifying non-small cell lung cancer patients that will benefit most from immune checkpoint inhibitors.
GelSight Partners with Meta AI to Democratize Digital Tactile Sensing
GelSight will commercially manufacture the DIGIT sensor to increase access and enable new tactile applications in robotics and beyond
InterVenn Presents Results at American Society for Mass Spectrometry Conference Demonstrating that Differential Peripheral Blood Glycoproteomic Signatures are Associated with Symptomatic vs. Asymptomatic Course of COVID-19 Infection
Results on the application of its perspectIV™ platform in COVID-19 patients demonstrate that glycoproteomic profiles in patients with a severe course of the infection are significantly different from those who experienced an asymptomatic course of the infection.
6K Appoints Gary Hall as Chief Financial Officer
Gary Hall joins 6K as Chief Financial Officer with over 20 years of experience leading finance and operational teams at high-growth, technology companies and helping these companies generate significant shareholder value through public and private offerings.